Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of a Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's Phenomenon
This study is ongoing, but not recruiting participants.
Study NCT00577304   Information provided by MediQuest Therapeutics
First Received: December 18, 2007   Last Updated: April 24, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Raynaud's Disease
Additional conditions recognized in this trial
Autoimmune Diseases
Neoplasm Metastasis
Raynaud Disease
More general conditions related to this trial
Cardiovascular Diseases
Immune System Diseases
Neoplasms
Neoplastic Processes
Pathologic Processes
Peripheral Vascular Diseases
Vascular Diseases
Interventions listed in this trial
Nitroglycerin
Topical AmphiMatrix
More general drug interventions related to this trial
Cardiovascular Agents
Pharmacologic Actions
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
MediQuest Therapeutics


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services